RxDoctor Payments Data

Mathew Gill, MD

Otolaryngology · Suwanee, GANPI 1376754200

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,032 of the $4,392 with a category attached, or 69.0%. 17 manufacturers reported payments, led by Smith+Nephew at 41.5% of the total. Reporting peaked in 2024 at $2,281 and has fallen 72.2% since, to $634 in 2025.

$4,392in general payments, 2019–2025

Across 68 payments — averaging $64.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Aerin Medical Inc.$661
  • Regeneron Healthcare Solutions, Inc.$463
  • Medtronic$369
  • Sanofi$256
  • Optinose US, Inc.$222
  • plus $598 from 11 others

What the payments were for

  • Travel & lodging$1,36031%
  • Food & beverage$3,03269%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,392 in reported general payments places this provider in the 85th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$87,377
Medicare patients
148
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide52$1,619
Azelastine Hcl35$986
Fluticasone Propionate63$633
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$385
Ofloxacin14$375
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$232
Omeprazole29$205
Doxycycline Hyclate14$171
Mupirocin28$168
Prednisone19$92
Ondansetron OdtOndansetron14$50
Triamcinolone Acetonide13$34

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Suwanee

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →